Steven Alsene succeeds Philip Carter as CEO of Rotech Healthcare Inc.

  Steven Alsene succeeds Philip Carter as CEO of Rotech Healthcare Inc.

                          Carter remains as Director

Business Wire

ORLANDO, Fla. -- December 10, 2012

Rotech Healthcare Inc. (OTCBB: ROHI.OB) (the “Company”) today announced the
appointment of Steven P. Alsene as President and Chief Executive Officer of
the Company effective January 1, 2013. Steve Alsene was also appointed to the
Board of Directors. Philip L. Carter will continue to serve as a member of the
Board of Directors.

Arthur J. Reimers, Chairman of the Board of Directors of the Company,
commented that the Board conducted a search for the Chief Executive Officer
position and that the Board is pleased to announce Mr. Alsene’s appointment.
Mr. Alsene has interacted closely with the Board for many years, has earned
the respect of the Board, and was the natural choice to become Chief Executive
Officer. Mr. Reimers also thanked Mr. Carter for his years of service to the
Company. He has guided the Company through many challenges and we are grateful
for his dedicated service to the Company. We now look forward to his continued
service as a Director of the Company.

As previously reported, Mr. Carter notified the Company in June 2012 of his
intention to retire as President and Chief Executive Officer on December 31,
2012. In August 2011, the Company amended Mr. Carter’s employment agreement
specifically in contemplation of Mr. Carter’s future retirement and to provide
for an orderly succession plan.

Mr. Carter, President and CEO, commented that Mr. Alsene is well positioned to
take on the leadership role at Rotech. At various times in his tenure at
Rotech, Mr. Alsene has had all of the key functions including Sales,
Operations, Billing, Finance, and Information Technology report to him. Mr.
Carter continued that he expects this transition of leadership to be smooth,
orderly, and well received by Company employees.

Mr. Alsene joined Rotech in June 2003 as the Vice President of Internal Audit
and also served as Vice President of Finance before becoming Chief Financial
Officer and Treasurer in September 2006. Most recently, he became Chief
Operating Officer of the Company on January 1, 2012. From June 1999 to June
2003, Mr. Alsene was the Head of Corporate Audit Services of Harcourt
Education, a division of Reed Elsevier PLC. From 1992 to 1999, Mr. Alsene
served in various audit department capacities including audit manager with
PricewaterhouseCoopers LLP. Mr. Alsene is a certified public accountant in the
State of Florida. He received his Bachelor of Science in Accounting from
Florida State University and holds a Masters in Accounting from Florida State
University.

About Rotech Healthcare Inc.

Rotech Healthcare Inc. is one of the largest providers of home medical
equipment and related products and services in the United States, with a
comprehensive offering of respiratory therapy and durable home medical
equipment and related services. The Company provides home medical equipment
and related products and services principally to older patients with breathing
disorders, such as chronic obstructive pulmonary diseases (COPD), which
include chronic bronchitis, emphysema, obstructive sleep apnea and other
cardiopulmonary disorders. The Company provides equipment and services in 49
states through approximately 420 operating locations located primarily in
non-urban markets.

Forward-Looking Statements

This press release contains certain statements that constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995 and the provisions of section 21E of the Securities Exchange Act of
1934, as amended, and section 27A of the Securities Act of 1933, as amended.
These forward-looking statements include all statements regarding the intent,
belief or current expectations regarding matters discussed in this press
release and all statements which are not statements of historical fact. Words
such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,”
“projects,” “may,” “will,” “could,” “should,” “would,” variations of such
words and similar expressions are intended to identify such forward-looking
statements. These forward-looking statements involve known and unknown risks,
uncertainties, contingencies and other factors that could cause results,
performance or achievements to differ materially from those stated or implied
in this press release. The following are some but not all of such risks,
uncertainties, contingencies, assumptions and other factors, many of which are
beyond the control of the Company, that could cause results, performance or
achievements to differ materially from those anticipated: general economic,
financial and business conditions; our ability to successfully transition and
retain patients associated with equipment and asset purchases; setting of new
reimbursement rates and other changes in reimbursement policies, the timing of
reimbursements and other legislative initiatives aimed at reducing health care
costs associated with Medicare and Medicaid; issues relating to reimbursement
by government and third-party payors for the Company's products and services
generally; the impact of competitive bidding on Medicare volume in the
impacted competitive bidding areas; the costs associated with government
regulation of the health care industry; health care reform and the effect of
changes in federal and state health care regulations generally; whether the
Company will be subject to additional regulatory restrictions or penalties;
issues relating to our ability to maintain effective internal control over
financial reporting and disclosure controls and procedures; compliance with
federal and state regulatory agencies, as well as accreditation standards and
confidentiality requirements with respect to patient information; the effects
of competition, industry consolidation and referral sources; recruiting,
hiring and retaining qualified employees and directors; compliance with
various settlement agreements and corporate compliance programs; the costs and
effects of legal proceedings; the Company's ability to meet our working
capital, capital expenditures and other liquidity needs; our ability to
maintain compliance with the covenants contained in our indentures for our
senior secured notes and our senior second lien notes; our ability to maintain
current levels of collectability on our accounts receivable; our ability to
successfully realize material improvements in bad debt expense levels and
revenue adjustments; and other factors as described in the Company's filings
with the Securities and Exchange Commission. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as
of the date thereof. The Company does not undertake any obligation to publicly
release any revisions to any forward-looking statements to reflect events or
circumstances after the date of this release or to reflect the occurrence of
unanticipated events.

Contact:

Rotech Healthcare
Philip L. Carter, 407-822-4600
President & Chief Executive Officer
 
Press spacebar to pause and continue. Press esc to stop.